Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2998 | Placebos Wiki | 0.24 |
| drug421 | Azithromycin Wiki | 0.16 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D004417 | Dyspnea NIH | 0.30 |
| D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.08 |
| D055371 | Acute Lung Injury NIH | 0.08 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002098 | Respiratory distress HPO | 0.30 |
| HP:0002090 | Pneumonia HPO | 0.05 |
Navigate: Correlations HPO
There is one clinical trial.
Dyspnea is defined by a subjective sensation of respiratory discomfort, the intensity of which varies according to the terrain, the anamnesis and the cause. Resuscitation is associated with many causes of dyspnea, including initial distress, mechanical ventilation, or after-effects following the pathology and its management. Respiratory distress is the most severe form of impaired lung function. It is the first cause of hospitalization in intensive care. This distress, indicative of the failure of the respiratory system, is always severe and potentially fatal. It therefore constitutes an absolute therapeutic emergency. Dyspnea is often the revealing symptom of the condition and the urgency surrounding its management is an additional factor of concern for the patient. As a result, dyspnea is a pejorative element associated with severity or even death.
Description: Multidimensional Dyspnea Profile (MDP) scale assessment of dyspnea
Measure: Evaluate the effect of exercise rehabilitation on post-ICU dyspnea Time: Day 1Description: Multidimensional Dyspnea Profile (MDP) scale assessment of dyspnea
Measure: Evaluate the effect of exercise rehabilitation on post-ICU dyspnea Time: 3 MonthsDescription: Assessment of dyspnea on the Modified Medical Research Council (mMRC) scale
Measure: Evaluate the effect of exercise rehabilitation on functional dyspnea Time: Day 1Description: Assessment of dyspnea on the Modified Medical Research Council (mMRC) scale
Measure: Evaluate the effect of exercise rehabilitation on functional dyspnea Time: 3 MonthsDescription: Short-Form Quality of Life Assessment (SF-12)
Measure: Evaluate the effect of stress rehabilitation on quality of life Time: Day 1Description: Short-Form Quality of Life Assessment (SF-12)
Measure: Evaluate the effect of stress rehabilitation on quality of life Time: 3 MonthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports